These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21903752)

  • 1. Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation.
    Lattif AA; Mukherjee PK; Chandra J; Roth MR; Welti R; Rouabhia M; Ghannoum MA
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3232-3242. PubMed ID: 21903752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.
    Prasad T; Saini P; Gaur NA; Vishwakarma RA; Khan LA; Haq QM; Prasad R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3442-52. PubMed ID: 16048959
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Uppuluri P; Acosta Zaldívar M; Anderson MZ; Dunn MJ; Berman J; Lopez Ribot JL; Köhler JR
    mBio; 2018 Aug; 9(4):. PubMed ID: 30131358
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
    Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
    Caldara M; Marmiroli N
    Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
    Vediyappan G; Rossignol T; d'Enfert C
    Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
    Pasrija R; Prasad T; Prasad R
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 governs dispersion and drug resistance of fungal biofilms.
    Robbins N; Uppuluri P; Nett J; Rajendran R; Ramage G; Lopez-Ribot JL; Andes D; Cowen LE
    PLoS Pathog; 2011 Sep; 7(9):e1002257. PubMed ID: 21931556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispersion as an important step in the Candida albicans biofilm developmental cycle.
    Uppuluri P; Chaturvedi AK; Srinivasan A; Banerjee M; Ramasubramaniam AK; Köhler JR; Kadosh D; Lopez-Ribot JL
    PLoS Pathog; 2010 Mar; 6(3):e1000828. PubMed ID: 20360962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns.
    García-Sánchez S; Aubert S; Iraqui I; Janbon G; Ghigo JM; d'Enfert C
    Eukaryot Cell; 2004 Apr; 3(2):536-45. PubMed ID: 15075282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the Inhibitory Activity and Possible Mechanism of Myriocin on Clinically Relevant Drug-Resistant Candida albicans and Its Biofilms.
    Yang X; Pei Z; Hu R; Zhang Z; Lou Z; Sun X
    Biol Pharm Bull; 2021 Mar; 44(3):305-315. PubMed ID: 33441497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of Candida albicans biofilm formation by cis-2-dodecenoic acid and trans-2-dodecenoic acid.
    Zhang Y; Cai C; Yang Y; Weng L; Wang L
    J Med Microbiol; 2011 Nov; 60(Pt 11):1643-1650. PubMed ID: 21778264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A.
    Munusamy K; Vadivelu J; Tay ST
    Rev Iberoam Micol; 2018; 35(2):68-72. PubMed ID: 29544734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis uncovers the modulation of ergosterol, sphingolipid and oxidative stress pathway by myristic acid impeding biofilm and virulence in Candida albicans.
    Prasath KG; Sethupathy S; Pandian SK
    J Proteomics; 2019 Sep; 208():103503. PubMed ID: 31454558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Identification of Biofilm-Specific Proteolysis in Candida albicans.
    Winter MB; Salcedo EC; Lohse MB; Hartooni N; Gulati M; Sanchez H; Takagi J; Hube B; Andes DR; Johnson AD; Craik CS; Nobile CJ
    mBio; 2016 Sep; 7(5):. PubMed ID: 27624133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for CaFEN1 and CaFEN12 of Candida albicans in cell wall integrity and biofilm formation.
    Alfatah M; Bari VK; Nahar AS; Bijlani S; Ganesan K
    Sci Rep; 2017 Jan; 7():40281. PubMed ID: 28079132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid raft polarization contributes to hyphal growth in Candida albicans.
    Martin SW; Konopka JB
    Eukaryot Cell; 2004 Jun; 3(3):675-84. PubMed ID: 15189988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
    Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
    mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.